home > events calendar > more about event

Respiratory Drug Delivery (RDD®) Europe 2019

RDD Europe 2019

7-10 May 2019
Estoril Congress Center, Lisbon

Respiratory Drug Delivery (RDD®) Europe 2019 connects emerging and high-level scientists, academics, industrial and regulatory specialists, and clinicians. It is a must-attend conference for companies involved in research, development, testing or marketing of medicines, devices and services associated with pulmonary or nasal pharmaceutical products. This year, RDD Europe 2019 will be held in Estoril (Lisbon), Portugal, May 7-10, 2019, and, as in previous years is jointly organized by RDD Online and Aptar Pharma.

The program features all new scientific content as befits this top-rated international conference, including:

•Expert presentations during themed sessions titled; New Approaches to Treating Old Diseases; Pipes, Particles and Predictions: New Insights into Deposition; Re-inventing Inhalers for the Digital Age; Take a Deep Breath: Brexit and Environmental Sustainability; and New Approaches to Inhalation Product Development and Production.

•A Technology Exhibition, in which excipient, device and equipment designers, component and service suppliers present their latest developments in a tabletop format.

•Workshop Sessions, featuring practical and interactive demonstrations of innovative technologies, products and services tailored to individual interests, such as connected health, excipient and device selection or product evaluation. 

•Scientific Posters, covering all aspects of regulatory science, formulation development, new research methods and advanced drug delivery technologies. This peer-reviewed session occurs alongside the Technology Exhibition. Accepted poster abstracts from graduate students are automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award, which covers the winning student's registration fee, travel expenses and accommodation up to a maximum of $2,000.

•Posters on the Podium, where particularly innovative poster abstracts are presented in the main auditorium.

• Networking Events, which enable delegates to maximize the benefits of attending RDD Europe 2019 by allowing time to reflect on and discuss ideas presented at the conference while meeting new collaborators and business partners in a range of formal and informal settings.

How to participate?

Registration is open and easy at All participants registering before January 21, 2019 benefit from a substantial discount, as do students and employees of academic and government agencies.

All podium speakers have been invited for RDD Europe 2019, but we welcome submission of talk titles and speaker nominations for RDD 2020. Potential speakers with novel data and insights are invited to submit a 200-word summary of their purpose and major findings to the Organizing Committee ( Each summary will be reviewed for originality, merit, and 'program fit' before invitations are issued.

The RDD Europe 2019 poster abstract submission deadline is January 7, 2019. It is a simple online process via RDD Online’s website: Click here to submit a Poster. Poster abstracts on all subjects related to pulmonary and nasal medication delivery are peer-reviewed prior to acceptance and publication.

Companies are invited to participate in the Technology Exhibition by sponsoring a table on which components, excipients, hardware or services may be displayed. Details and sign-up for table sponsorship are available at

You can find more detailed information on the conference and the different sponsorship opportunities to maximize the value of your participation on the conference web site

phone +1 (804) 827-1490
email Estoril Congress Center, Lisbon
Print this page
Send to a friend
Industry Events

ELRIG Drug Discovery 2019 – Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

News and Press Releases

Sartorius debuts the Intellicyt iQue3 at CYTO® 2019

Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3. The event – which takes place in Vancouver, Canada, from June 22 to 26 – will give delegates the chance to explore a smarter way to perform flow cytometry experiments.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement